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وبائيات سرطان الثدي عند النساء البحرينيات
معطيات سجل السرطان البحريين
رنده حماده، جناة ابوالفاحت، ماجده فكري، هاله املهزه
abstract: Objectives: The aim of this study was to describe the epidemiology of breast cancer among the Bahraini 
female population in the years 2000‒2010 and examine its health policy implications. Methods: All breast cancer 
cases in the Bahrain Cancer Registry from 1st January 2000 to 31st December 2010 were included. Results: There 
were 1,005 cases, 12.7% of which were detected by screening. The overall mean age at diagnosis was 50.9 years (95% 
confidence interval 50.1–51.6). The age-standardised incidence rate declined from 58.2 per 100,000 in 2000 to 44.4 
per 100,000 in 2010. The majority of cases were infiltrating ductal carcinoma (76.9%). Of the registered cases, 44.1% 
and 48.1% had an unknown grade and stage, respectively. The five-year survival rate was 63 ± 2%. Conclusion: The 
low percentage of cases detected by screening merits further evaluation of Bahrain’s screening programme. More 
effort should be made to reduce the proportion of unknown stage and grade breast cancers. Future research has to 
be directed towards understanding the reasons for Bahrain having the highest incidence rate of breast cancer in the 
Gulf Cooperation Council countries.
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امللخ�ص: الهدف: وصف وبائيات سرطان الثدي بني السكان البحرينيات اإلناث خالل الفرتة بني 2010-2000م ودراسة السياسات املرتتبة عليها. 
الطريقة: مت اإدراج جميع حالت �رشطان الثدي امل�صجلة يف �صجل ال�رشطان البحريني من الأول من يناير 2000م اإىل الواحد والثلثني من دي�صمرب 2010م. 
 CI 95%( النتائج: مت ت�صجيل 1,005 حالة، منها %12.7 اكت�صفت  بوا�صطة الفح�س الدوري. وكان متو�صط  العمر العام عند الت�صخي�س 50.9 عام
51.6، 50.1(. وقد انخف�س معدل الإ�صابة املوحد للعمر من 58.2/100000 يف عام 2000 اإىل/44.4/100,000 يف عام 2010. وقد كانت معظم 
احلالت من نوع �رشطان الأقنية املت�صلل )%76.9(. مل يتم التعرف على درجة ومرحلة ال�رشطان لدى %44.1 و %48.1 من الن�صاء على التوايل. وكان 
معدل ن�صبة البقاء ملدة خم�صة اأعوام على قيد احلياة %2 ± 63. اخلال�صة: اإن انخفا�س ن�صبة احلالت املكت�صفة عن طريق الفرز الدوري ت�صتحق املزيد من 
التقييم لهذا الربنامج. وينبغي بذل املزيد من اجلهود للحد من ن�صب احلالت غري املعروفة الدرجة واملرحلة. يجب على الأبحاث امل�صتقبلية الرتكيز على فهم 
اأ�صباب ارتفاع ن�صبة الإ�صابة ب�رشطان الثدي يف البحرين مقارنة بدول جمل�س التعاون اخلليجي.
مفتاح الكلمات: سرطان الثدي؛ علم الوبائيات؛ نسبة االنتشار؛ الفحص الدوري؛ نسبة البقاء؛ البحرين؛ دول جملس التعاون اخلليجي. 
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Advances in Knowledge 
- There is a lack of concrete data about the epidemiology of breast cancer in Arab nations. This study reports on the incidence of breast 
cancer in Bahrain over an 11-year period and describes cancer registration in Bahrain.
- This study also identifies deficiencies in cancer registration and areas for improvement in the registry and breast screening programmes 
in the country.
Application to Patient Care
- This study has implications for the evaluation and modification of Bahrain’s on going breast screening programme and guidelines.
Worldwide, breast cancer is the commonest cancer among females. It is estimated that more than 1.6 million 
new cases of breast cancer occurred among women 
globally in 2010.1 There is great variation between 
the incidence rates of breast cancer in developed 
countries in comparison to developing countries. In 
2008, incidence rates ranged from 19.3 per 100,000 
women in Eastern Africa to 89.9 per 100,000 women 
in Western Europe. The rates were high (>80 per 
100,000) in developed countries, except for Japan, and 
low (<40 per 100,000) in most developing regions.2
Breast cancer occupies the first rank among 
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all female cancers in all Arab countries despite the 
fact that some rates are relatively low (20‒30 per 
100,000).3,4 Patients tend to be young with an average 
age at presentation of 48 ± 2.8 years, which is a decade 
earlier than in Western countries.5,6 In the six Gulf 
Cooperation Council (GCC) countries, breast cancer 
is the commonest female cancer. Compared to all 
female cancers, the proportion of breast cancer ranged 
from 15.7% in Oman to 54.4% in Bahrain.7 Bahrain, 
Kuwait and Qatar were classified as high-incidence 
countries while the United Arab Emirates, Saudi 
Arabia and Oman were low-incidence. A comparison 
of the age-standardised rate (ASR) of breast cancer 
from high-incidence GCC countries with other 
countries shows that the GCC rates are similar to 
those of some European countries, meaning that the 
rates are higher than in Japan, but still lower than 
those of high-incidence countries like the USA [Figure 
1]. Most international and interethnic differences in 
the incidence of breast cancer have been attributed 
to the varying environmental factors and lifestyles of 
the populations.8 However, the disparities observed 
within the GCC region have been explained partly 
by the differences in fertility rates and the duration of 
breastfeeding.8
Cancer is the second leading cause of death in 
Bahrain (10%), following cardiovascular diseases.9 
However, the proportional mortality rate of cancer 
has been underestimated due to the high percentage 
of ill-defined causes of death.10 In a Ministerial Decree 
in 1994, cancer notification became mandatory. Thus, 
all physicians in Bahrain became obliged to report all 
cancer cases to the Bahrain Cancer Registry (BCR) at 
the Medical Review Office of the Ministry of Health 
(MOH).12 Compared to other GCC states, Bahrain 
has a higher incidence of cancers of the breast, lung, 
bladder, thyroid, uterus and ovary among females. A 
rising trend in cancer incidence is likely to continue 
for years or even decades to come. In Bahraini females, 
breast cancer remains the leading type of cancer.13,14
Breast cancer screening in Bahrain started in 
December 1992 for women aged 30‒64 years old 
and included educational activities on clinical breast 
examination (CBE) and breast self-examination.15 
Screening by mammography was only performed for 
suspected and high-risk cases after referral. Between 
2008‒2010, the primary healthcare centres in Bahrain 
reported a CBE coverage rate of 6.6%, 7.1% and 
6.9%, respectively, in women 30 years and above.9 
Mammography screening of Bahraini women 40 
years and over was started in September 2005 with 
a recommendation for it to be performed every two 
years.16
Methods
The breast cancer cases included in the study were those 
in Bahraini patients registered in the BCR between 1st 
January 2000 and 31st December 2010. Incidence rates 
were calculated using CanReg4 software (Descriptive 
Epidemiology Unit, International Association of 
Cancer Registries, Lyon, France), in which the yearly 
crude incidence rate, age-specific incidence rates 
(ASPIRs) and age-standardised incidence rates (ASIRs) 
were computed. Incidence rates were standardised 
for age and sex by the direct standardisation method 
using the world standard population. Women were 
considered premenopausal if they were below 50 years 
and postmenopausal if they were 50 years old or above.
Data analysis was performed using the Statistical 
Package for the Social Sciences, Version 20.0 (IBM, 
Corp., Chicago, Illinois, USA). Analysis of variance 
(ANOVA) and least significant difference tests were 
performed to detect differences in age means. Pearson’s 
chi-squared test was used to detect differences 
between premenopausal and postmenopausal 
age groups by type, grade, laterality and detection 
modality. Survival analysis was done using the life 
table technique. The probability of patient survival 
in each interval was calculated by taking account of 
the census observations in that interval. The survival 
proportion included only the overall survival—not the 
relapse-free survival. Breast cancer patients diagnosed 
with only a death certificate were excluded from the 
survival analysis due to the lack of a diagnosis date. The 
Wilcoxon-Gehan statistic was utilised to determine 
the five-year survival differences by age group, grade, 
Figure 1: Age-standardised world incidence rates in 
Bahrain and selected countries calculated per 100,000 
cases of breast cancer.
Figure reproduced with blanket permission: International Agency for Research on Cancer 
and World Health Organization. GLOBOCAN: Estimated Cancer Incidence, Mortality 
and Prevalence Worldwide.11
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stage and detection modality. Ethical approval was 
obtained from the Research & Ethics Committee of 
the MOH in Bahrain.
Results
Between 2000‒2010, 1,005 breast cancer cases 
were registered in the BCR, of which 28.7% were 
still alive by the end of the study period. The annual 
average number of cases was 91, with 2007 having 
the highest reported number (120) and 2002 the 
lowest (66). About three-quarters of the women were 
married (74.7%) with 12.5% single, 2.3% divorced, 
6.1% widowed and the rest unknown (4.4%). The 
proportion of premenopausal women diagnosed was 
51.2% while 48.8% were postmenopausal [Table 1]. 
The median age at diagnosis during the 11-year period 
was 49 years while the average age was 50.9 years 
(95% confidence interval [CI] 50.1–51.6). There was 
a statistically significant difference (P <0.05) in mean 
age, with an increase in the mean age from the year 
2000 to 2010. The lowest mean ages at diagnosis were 
48.5 in 2000 and 48.0 in 2001 while the highest mean 
age at diagnosis was 53.9 in 2006.
The majority of the reported cases were from 
the Salmaniya Medical Complex and the Bahrain 
Defence Force Hospital (91.4%) which are the main 
governmental general hospitals. The screening 
programme contributed to the diagnosis in 1.5% of 
the cases. Over half of the patients were diagnosed 
based on a primary histological diagnosis [Table 1]. 
The average breast cancer ASIR in Bahrain was 
52.3 per 100,000. The ASIRs declined from 58.2 
per 100,000 in 2000 to 44.4 per 100,000 in 2010 
[Figure 2]. The ASPIRs of the postmenopausal women 
Figure 2: Age-standardised incidence rates of breast cancer by 
year of diagnosis.
Figure 3:  Incidence rates in premenopausal and 
postmenopausal women by year.
Table 1: Characteristics of breast cancer patients 
(N = 1,005)
Characteristics n %













Salmaniya Medical Complex 833 82.9
Bahrain Defense Force Hospital 85 8.5
Private hospitals 8 0.8
Private clinics 11 1.0
Primary healthcare 34 3.4
Breast cancer screening programme 15 1.5
Unknown 19 1.9
Basis of diagnosis
Death certificate only 12 1.2
Clinical only 1 0.1
Clinical investigation/ultrasound 6 0.6
Cytology/haematology 384 38.2
Histology of metastasis 10 1.0
Histology of primary cancer 586 58.3
Unknown 6 0.6
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were generally higher than those of premenopausal 
women throughout the period. There was a noticeable 
variation in the rates of the postmenopausal 
women with a peak in 2006 while the rates of the 
premenopausal women had little variation [Figure 
3]. Analysis by five-year age group showed that the 
age groups 65‒69 and 50‒54 had the highest overall 
average ASPIR during the 11-year period (184 per 
100,000 and 179.8 per 100,00, respectively) and those 
of the 20‒24 age group (2.4 per 100,000) and 25‒29 age 
group (8.7 per 100,000) had the lowest.
Table 2 shows that the majority of breast cancer 
cases were infiltrating ductal carcinoma (76.9%) and 
grade 2 moderately differentiated tumours (28.6%) 
with regional and distant metastasis (35.1%). Both 
breasts were found to be equally affected. High 
proportions of cancers of unknown grade (44.1%) and 
stage (48.1%) were noted.
Although only 15 cases were notified through the 
breast cancer screening project, 113 more were detected 
by the tumour registrar while reviewing medical 
records, yielding 12.7% of the total cases through 
screening and 87.3% through routine notification 
[Table 2]. There was a statistically significant 
difference (P = 0.0043) among premenopausal and 
postmenopausal women whereby a higher proportion 
of the latter was detected by screening. Further analysis 
by year showed a statistically significant decline 
in the proportion of cases detected by screening 
(P <0.0001) reaching 13.0%, in 2010.
It was found that 57 patients (5.7%) did not 
undergo any treatment while 31 (3.1%) had an 
unknown modality of treatment. Surgery (84.7%) 
was the commonest modality performed for breast 
cancer patients, followed by chemotherapy (63.0%), 
radiotherapy (50.2%) and hormonal therapy (8.7%).
There was a progressive decline in the proportion 
of breast cancer patients’ cumulative survival by year. 
After one year, 84.0% ± 1.0% survived in contrast 
to 63.0% ± 2.0% and 49.0% ± 3.0% respectively, for 
the five- and ten-year intervals. Table 3 shows the 
cumulative proportion surviving at the end of the 
five-year interval by age, grade, stage and detection 
modality. Women diagnosed at the age of 35 years or 
younger had a 73.0% ± 5.0% survival rate compared to 
51.0% ± 5.0% in those 65 years old and over. There was 
an inverse relationship between grade and five-year 
survival whereby it reached 50.0% ± 35.0% in grade 
four (undifferentiated anaplastic) compared to 78.0% 
± 8.0% in grade one (well-differentiated). Patients 
with unknown grades of cancer had a 58.0% ± 3.0% 
survival.
A similar inverse relationship was noted with 
respect to stage; however, those with an unknown 
stage of cancer had a higher five-year survival rate 
(62%). Further, those detected by screening had a 4% 
higher survival rate (65%) than those detected via 
routine examination (61%). There were significant 
differences (P <0.009) in the five-year survival rate 
with respect to age, stage and detection modality. A 
lower cumulative survival rate at five years was found 
among older women, patients with cancers that had 
advanced to a higher grade or advanced stage, and 
cancers detected through a routine check-up.
Discussion
The BCR is a reliable national population-based registry 
covering all residents (Bahraini and non-Bahraini) in 
the country; it gathers information on epidemiological, 
clinical and pathological aspects of the disease. 
Bahrain’s cancer data is entered into the CanReg4 
software and doctors started reporting this data to 
the Cancer Incidence in Five Continents publication 
in 2007.13 Only five other countries (Kuwait, Oman, 
Algeria, Egypt and Tunisia) appeared in that volume; 
however, Jordan, Palestine, Saudi Arabia and Qatar 
also have population-based registries.3
Breast cancer is the commonest cancer among 
females in Bahrain.14 The average breast cancer ASIR 
in Bahrain (52.3 per 100,000) is the highest among 
all GCC states.7 All other Eastern Mediterranean 
countries, except for Lebanon (55.4 per 100,000), 
have rates that are higher than the world average (39.0 
per 100,000) and that of less developed regions (27.3 
per 100,000), but lower than that of more developed 
regions (66.4 per 100,000).2 The rates declined from 
58.2 per 100,000 in 2000 to 44.4 per 100,000 in 
2010. This is in contrast to the trends of other GCC 
countries but in accord with those of some developed 
countries.7,17 Similar to other studies, breast cancer 
risk in Bahrain increases with age.18 The highest 
overall average ASPIR was 184 per 100,000 in patients 
between 65‒69 years followed by 179.8 per 100,000 in 
those between 50‒54 years. Those aged 65‒69 years 
had the highest rate, as was also seen in Kuwait.7
The mean age at presentation for breast cancer 
in Arab countries is reported to be a decade earlier 
than Western countries.3,6 This difference could 
be attributed to social, economic and population 
differences in the age at diagnosis between Arab and 
Western populations.6 The median age at diagnosis (49 
years) is similar to what has been reported from other 
Arab countries (48.5 years) but lower than the age at 
diagnosis in industrialised countries (63 years).6 The 
overall mean age at diagnosis (50.9; 95% CI: 50.1–51.6 
years) is slightly lower than that reported for Kuwaiti 
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Table 2: Type, grade, stage, laterality and detection modality of cases (N = 1,005)
Premenopausal Postmenopausal Total P value
n % n % n %
Type
Infiltrating ductal carcinoma 413 80.2 360 73.5 773 76.9
0.010
NOS lobular carcinoma 25 4.9 24 4.9 49 4.9
Unclassified neoplasm 18 3.5 31 6.3 49 4.9
NOS carcinoma 19 3.7 23 4.7 42 4.2
Infiltrating ductal and lobular carcinoma 8 1.6 5 1.0 13 1.3
NOS adenocarcinoma 8 1.6 14 2.9 22 2.2
Other 24 4.7 33 6.7 57 5.6
Grade
1 Well-differentiated 15 2.9 35 7.1 50 5.0
0.005
2 Moderately differentiated 145 28.2 142 29.0 287 145
3 Poorly differentiated 131 25.4 91 18.6 222 22.1
4 Undifferentiated and anaplastic 2 0.4 1 0.2 3 0.3
Unknown 222 43.1 221 45.1 443 44.1
Stage
In situ 12 2.3 12 2.4 24 2.4
0.713
Localised 71 13.8 74 15.1 145 14.4
Regional direct extension 11 2.1 17 3.5 28 2.8
Regional lymph nodes 93 18.1 82 16.7 175 17.4
Regional direct extension and lymph nodes 8 1.6 8 1.6 16 1.6
Distant metastasis 63 12.2 71 14.6 134 13.3
Unknown 257 49.9 226 46.1 483 48.1
Laterality
Right 260 50.5 214 43.7 474 47.1
0.193
Left 231 44.9 250 51.0 481 47.9
Bilateral 9 1.7 9 1.8 18 1.8
Paired lateral unknown 15 2.9 17 3.5 32 3.2
Detection modality
Routine 465 90.3 412 84.1 877 87.3
0.004
Screening 50 9.7 78 15.9 128 12.7
Total 515 100.0 490 100.0 1,005 100.0
NOS = non-specific.
females (52.3; 95% CI: 51.7–52.9 years).19 However, 
it is higher than that reported for Bahrain between 
1998‒2002 (49.0 ± 12.5 years)5 and for Iran (46 ± 
12.5 years).20 The increase in mean age at diagnosis 
can be partially explained by the older population 
targeted by the screening programme. The results of 
the current study have shown that a higher proportion 
of postmenopausal (15.9%) cancers were detected by 
screening than those in premenopausal women (9.7%).
The commonest type of breast cancer found in 
Bahrain in this study was infiltrating ductal carcinoma 
(76.9%), a similar result to that reported for all GCC 
states combined (76.8%).7 As was found in Kuwaiti 
and Saudi Arabian studies, in Bahrain both breasts 
were equally affected.19,21 The fact that there was a 
considerable number of cases with an unknown grade 
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(44.1%) and stage (48.1%) of cancer is disappointing. 
Having three cases of undifferentiated anaplastic 
grade could have been an underestimate due to the 
high percentage of cases with an unknown grade. 
This reflects the incompleteness of the data and 
underestimates the true grades and stages. However, 
the proportion with regional and distant metastasis 
doubled when the unknown grade cases were excluded 
and became similar to that of Kuwait (68%) but higher 
than that of Saudi Arabia (58.9%).19,21 The BCR does 
not include full details on the types of treatment. 
Surgery was the commonest modality in Bahrain, as 
has also been reported in Kuwait.22
The cumulative five-year survival rate among 
Bahraini breast cancer patients (63% ± 2%) was 
slightly lower than that reported in an earlier study 
(68.8%) that was based on patients from the Salmaniya 
Medical Complex prior to the establishment of the 
BCR. In contrast, the 10-year survival rate found in 
that study was higher (49% ± 3%) than the current 
study’s findings (36.4%).23 The five-year survival rate in 
the current study lies midway between the lowest rate 
reported among developing countries (45%) and the 
highest rate among developed countries (89%).8 It is 
also lower than that previously reported for Iran (72%) 
but is similar to the rate found in Saudi Arabia (63.1%) 
for 2000‒2004.20,24 Further, the fact that there were 
high proportions of breast cancer cases with unknown 
stage and grade might have affected the survival results 
among premenopausal and postmenopausal women.
Female breast cancer risk factors in the Arab 
world are similar to those of Western countries.3 
Globally, high breast cancer incidence rates are 
associated with a high prevalence of reproductive risk 
factors.17 The decline in total fertility rates, the delay 
in the age of having one’s first child, the shorter mean 
duration of breastfeeding and the increased early 
detection through screening underlie the high rates 
in Bahrain.8,13,14 Further, early menarche (mean age 
12.7 ± 1.7 years) was reported among breast cancer 
patients in Bahrain.25 Lifestyle changes, including 
sedentary lifestyles, physical inactivity, Westernised 
diets, high-calorie diets and obesity, contribute to the 
high incidence rates of breast cancer in Bahrain.26‒28 In 
addition, the possibility of certain genetic dispositions 
may explain the higher Bahraini incidence rate 
compared to other GCC states.4,14
Breast cancer is a major public health burden in 
Bahrain that should be addressed by a multidisciplinary 
collaborative approach and an understanding of 
the unique risk factors.29 There is an ongoing debate 
over the benefits and harm of breast screening and 
new approaches should be considered.30,31 The fact 
that patients whose cancers had been detected by 
screening had higher survival rates is reassuring. The 
marked decrease in case detection with time can be 
partially explained by the possible inconsistency in 
the screening awareness programme campaigns and 
a lack of awareness among physicians and the public. 
Moreover, there is no comprehensive evaluation of the 
screening programme.29 Further, the low percentage 
(12.7%) of cases detected by screening merits 
further evaluation of the Bahraini cancer prevention 
programme.













<35 0.73 ± 0.05
21.315 <0.0001
35‒49 0.63 ± 0.03
50‒64 0.67 ± 0.03
≥65 0.51 ± 0.05
Grade
1 0.78 ± 0.08
25.903 <0.0001
2 0.68 ± 0.04
3 0.66 ± 0.04
4 0.50 ± 0.35
Unknown 0.58 ± 0.03
Stage
In situ 1.0 ± 0.0
76.294 <0.0001











Distant metastasis 0.31 ± 0.05
Unkown 0.63 ± 0.02
Detection modality





<0.0001Screening 0.65 ± 0.22
Overall 0.63 ± 0.02
SD = standard deviation; Grade 1 = well-differentiated; Grade 2 = 
moderately differentiated; Grade 3 = poorly differentiated; Grade 4 = 
undifferentiated and anaplastic.
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Conclusion
Breast cancer is a major public health burden which 
warrants the attention of health policy-makers. An 
evaluation of the Bahraini breast cancer screening 
programme, including the ideal age to start screening, 
and a re-evaluation of the national guidelines is 
urgently needed. More effort should be made to 
reduce the proportion of cancers of unknown stage 
and grade. Data on breast cancer risk factors, such 
as early menarche, hormonal receptors, age at the 
birth of the first child and oral contraceptive and 
hormone replacement therapy use are characteristics 
that should be further considered in breast cancer 
epidemiology research in Bahrain. Future research 
should be directed towards collaborative regional 
analytical studies to understand the multifaceted role 
of the interactive risk factors of breast cancer. Such 
research should also clarify the reasons why Bahrain 
has the highest breast cancer incidence rate among the 
GCC states and one of the highest rates in the Eastern 
Mediterranean region.
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